Mammary analogue secretory carcinoma: An Indian experience of a novel entity

Aims: To explore clinical, histopathological and immunohistochemistry (IHC) features of mammary analogue secretory carcinoma (MASC) with systematic literature review. Settings and Design: Hospital based cross-sectional study. Subjects and Methods: The data of all cases of MASC diagnosed over a perio...

Full description

Bibliographic Details
Main Authors: Zeba Nisar, Jaydeep N Pol, Rakhi V Jagdale, Madhura D Phadke, Girish A Kadkol
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=5;spage=134;epage=140;aulast=Nisar
_version_ 1817989160025194496
author Zeba Nisar
Jaydeep N Pol
Rakhi V Jagdale
Madhura D Phadke
Girish A Kadkol
author_facet Zeba Nisar
Jaydeep N Pol
Rakhi V Jagdale
Madhura D Phadke
Girish A Kadkol
author_sort Zeba Nisar
collection DOAJ
description Aims: To explore clinical, histopathological and immunohistochemistry (IHC) features of mammary analogue secretory carcinoma (MASC) with systematic literature review. Settings and Design: Hospital based cross-sectional study. Subjects and Methods: The data of all cases of MASC diagnosed over a period of 1 year i.e., from July 2017 to July 2018 were retrieved. The haematoxylin and eosin (H and E) sections, and IHC sections were studied. A strict histological and recently updated criteria were applied and patients with a confirmed diagnosis of MASC were included in the study. A systematic literature review was conducted by searching the PubMed and National Centre for Biotechnology Information database. Statistical Analysis Used: Microsoft Excel 2010. Results: The present case series is 27th in the English literature and 1stcase series describing its histopathology in the Indian literature. The mean age of presentation is 43 years. Female preponderance was found i.e., M:F ratio of 0.5. Conclusion: Histopathology and if necessary, followed by IHC is required for the confirmation of diagnosis of MASC. We should be aware about this recently described entity which is usually mistaken for other low grade salivary gland carcinomas like Acinic cell carcinoma (AciCC) and Mucoepidermoid carcinoma (MEC). The knowledge about its typical morphology, high degree of suspicion and IHC confirmation with both S-100 and Mammaglobin help in precise diagnosis.
first_indexed 2024-04-14T00:42:36Z
format Article
id doaj.art-9e59542353cd4a86aa938db7995b8b11
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-04-14T00:42:36Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-9e59542353cd4a86aa938db7995b8b112022-12-22T02:22:08ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292020-01-0163513414010.4103/IJPM.IJPM_757_18Mammary analogue secretory carcinoma: An Indian experience of a novel entityZeba NisarJaydeep N PolRakhi V JagdaleMadhura D PhadkeGirish A KadkolAims: To explore clinical, histopathological and immunohistochemistry (IHC) features of mammary analogue secretory carcinoma (MASC) with systematic literature review. Settings and Design: Hospital based cross-sectional study. Subjects and Methods: The data of all cases of MASC diagnosed over a period of 1 year i.e., from July 2017 to July 2018 were retrieved. The haematoxylin and eosin (H and E) sections, and IHC sections were studied. A strict histological and recently updated criteria were applied and patients with a confirmed diagnosis of MASC were included in the study. A systematic literature review was conducted by searching the PubMed and National Centre for Biotechnology Information database. Statistical Analysis Used: Microsoft Excel 2010. Results: The present case series is 27th in the English literature and 1stcase series describing its histopathology in the Indian literature. The mean age of presentation is 43 years. Female preponderance was found i.e., M:F ratio of 0.5. Conclusion: Histopathology and if necessary, followed by IHC is required for the confirmation of diagnosis of MASC. We should be aware about this recently described entity which is usually mistaken for other low grade salivary gland carcinomas like Acinic cell carcinoma (AciCC) and Mucoepidermoid carcinoma (MEC). The knowledge about its typical morphology, high degree of suspicion and IHC confirmation with both S-100 and Mammaglobin help in precise diagnosis.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=5;spage=134;epage=140;aulast=Nisaretv6-ntrk3 gene fusionmammaglobinmammary analogue secretory carcinoma
spellingShingle Zeba Nisar
Jaydeep N Pol
Rakhi V Jagdale
Madhura D Phadke
Girish A Kadkol
Mammary analogue secretory carcinoma: An Indian experience of a novel entity
Indian Journal of Pathology and Microbiology
etv6-ntrk3 gene fusion
mammaglobin
mammary analogue secretory carcinoma
title Mammary analogue secretory carcinoma: An Indian experience of a novel entity
title_full Mammary analogue secretory carcinoma: An Indian experience of a novel entity
title_fullStr Mammary analogue secretory carcinoma: An Indian experience of a novel entity
title_full_unstemmed Mammary analogue secretory carcinoma: An Indian experience of a novel entity
title_short Mammary analogue secretory carcinoma: An Indian experience of a novel entity
title_sort mammary analogue secretory carcinoma an indian experience of a novel entity
topic etv6-ntrk3 gene fusion
mammaglobin
mammary analogue secretory carcinoma
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=5;spage=134;epage=140;aulast=Nisar
work_keys_str_mv AT zebanisar mammaryanaloguesecretorycarcinomaanindianexperienceofanovelentity
AT jaydeepnpol mammaryanaloguesecretorycarcinomaanindianexperienceofanovelentity
AT rakhivjagdale mammaryanaloguesecretorycarcinomaanindianexperienceofanovelentity
AT madhuradphadke mammaryanaloguesecretorycarcinomaanindianexperienceofanovelentity
AT girishakadkol mammaryanaloguesecretorycarcinomaanindianexperienceofanovelentity